|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Stakeholder Opinions: Vaccine adjuvants - uncertainties rule
Overview of adjuvants for prophylactic vaccines with detailed profiles and critical assessment of key products. Discussion of the regulatory environment with strategic recommendations for adjuvant developers to optimize chances of market approval.
Cancer Vaccines: Aim and Shoot
This report aims to analyze the current and future potential of cancer vaccines by examining key fundamentals across the entire pipeline of cancer vaccine drug candidates.
Cancer Vaccines Fantasy or Future?
In this newly updated progress analysis, BioSeeker not only provide a solid background and information structure, we also bring the latest within cancer vaccine achievements.
Therapeutic Vaccines: More Trials and Tribulations
Therapeutic vaccines have faced numerous setbacks in recent years. The only three vaccines to reach the market have had insignificant sales, while the pipeline has seen numerous high-profile failures and no new product launches in three years. However
The Vaccines Market Outlook: Market analysis
This unique report provides unrivalled analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, and also includes company reported sales data allowing you to spot any discrepancies between the
Commercial Perspectives: Vaccines - Nosocomial Pathogens
The vaccines sector is undergoing a period of growth, making it a more attractive market to pharmaceutical companies. In addition, changing population demographics, competition and new technologies are further transforming this area. Indeed, novel vacc
Commercial Insight: Vaccines - Reaching Adulthood
The vaccine sector has historically been dominated by five key companies, which derived value from high volume sales or relatively cheap commodity vaccine products. However, recent years have seen the introduction of higher-value offerings, such as Wye
Cancer Vaccines: Drug Pipeline Update 2008
There are today more than 235 cancer vaccines, from early preclinical to marketed drugs. Cancer Vaccines Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 91 different targets. Th
Stakeholder Opinions: Gastric Cancer - Targeted Therapies...
Despite declining incidence rates, gastric cancer remains the second most common tumor type and second cause of cancer-related death worldwide. Gastric cancer occurs nearly five times more frequently in Japan than in the West. While early diagnosis an
Competitive Outlook on Non-Antibody Based Cancer Vaccines
Research and development in the cancer vaccine field is dominated by its top 10 players, interestingly not including any of the big pharma companies per se. The recent Gardasil approval and GlaxoSmithKline’s acquisition of Corixa will certainly
Triple Analysis: Melanoma, Antibodies and Vaccines in Oncology
In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Melanoma Therapeutics, Antibodies and Vaccines in Oncology, which are all subjects to an extensive number of innovative drug candidates. This
The Complete Guide to Targeted Therapies in Oncology
In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology.
Pipeline Insight: Therapeutic Cancer Vaccines
Unmet needs across the cancer market remain high, with most therapies conferring low levels of specificity and high toxicity. Therapeutic cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity
Results 1 - 21 of 21
|
